Press Releases Stay on top of the latest news from Poseida Therapeutics. Learn about our leading-edge cell and gene therapy programs, from new discoveries to clinical trials, and get the most recent investor news. IR Sub Menu Investors & Media Corporate Profile Press Releases Events & Presentations Publications Year None2021202020192018201720162015 Poseida Therapeutics to Present at American Society of Gene and Cell Therapy 2021 Annual Meeting 04/27/2021 Poseida Therapeutics to Present at Upcoming Virtual Investor Conferences 04/08/2021 Poseida Therapeutics Announces Carl June, M.D., to Chair Immuno-Oncology Scientific Advisory Board 03/23/2021 Poseida Therapeutics Reports Program Updates and Financial Results for the Fourth Quarter and Full Year 2020 03/11/2021 Poseida Therapeutics Provides Update on Key Programs and Developments During R&D Day 02/24/2021 Poseida Therapeutics to Host Virtual R&D Day on February 24, 2021 02/10/2021 Poseida Therapeutics to Participate in Guggenheim Healthcare Talks 2021 Oncology Day 02/04/2021 Poseida Therapeutics to Participate in SternIR Virtual Corporate Access Event 01/04/2021 Poseida Therapeutics Added to NASDAQ Biotechnology Index 12/18/2020 Poseida Therapeutics Appoints Luke Corning to Board of Directors 12/17/2020 Pagination First page « first Previous page ‹ previous Page 1 Current page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Next page next › Last page last » Displaying 11 - 20 of 75
Year None2021202020192018201720162015 Poseida Therapeutics to Present at American Society of Gene and Cell Therapy 2021 Annual Meeting 04/27/2021 Poseida Therapeutics to Present at Upcoming Virtual Investor Conferences 04/08/2021 Poseida Therapeutics Announces Carl June, M.D., to Chair Immuno-Oncology Scientific Advisory Board 03/23/2021 Poseida Therapeutics Reports Program Updates and Financial Results for the Fourth Quarter and Full Year 2020 03/11/2021 Poseida Therapeutics Provides Update on Key Programs and Developments During R&D Day 02/24/2021 Poseida Therapeutics to Host Virtual R&D Day on February 24, 2021 02/10/2021 Poseida Therapeutics to Participate in Guggenheim Healthcare Talks 2021 Oncology Day 02/04/2021 Poseida Therapeutics to Participate in SternIR Virtual Corporate Access Event 01/04/2021 Poseida Therapeutics Added to NASDAQ Biotechnology Index 12/18/2020 Poseida Therapeutics Appoints Luke Corning to Board of Directors 12/17/2020 Pagination First page « first Previous page ‹ previous Page 1 Current page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Next page next › Last page last » Displaying 11 - 20 of 75
Poseida Therapeutics to Present at American Society of Gene and Cell Therapy 2021 Annual Meeting 04/27/2021
Poseida Therapeutics Announces Carl June, M.D., to Chair Immuno-Oncology Scientific Advisory Board 03/23/2021
Poseida Therapeutics Reports Program Updates and Financial Results for the Fourth Quarter and Full Year 2020 03/11/2021